Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 16,330
-570 (-3.37%)
At close: Jun 5, 2026
Cell Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 111,761 | 89,724 | 97,662 | 76,789 | 86,918 | 133,300 | |
Market Cap Growth | 28.79% | -8.13% | 27.18% | -11.65% | -34.80% | -19.84% |
Enterprise Value | 17,453 | 1,343 | 19,190 | 10,612 | 22,959 | 70,193 |
Last Close Price | 16330.00 | 13110.00 | 13643.66 | 10388.77 | 11289.59 | 16183.18 |
PE Ratio | 8.33 | 8.86 | 6.46 | 12.18 | 10.50 | 12.84 |
Forward PE | - | 8.16 | 8.16 | 8.16 | 8.16 | 8.16 |
PS Ratio | 1.98 | 1.69 | 1.96 | 1.43 | 1.72 | 2.84 |
PB Ratio | 0.84 | 0.68 | 0.79 | 0.69 | 0.80 | 1.25 |
P/TBV Ratio | 0.85 | 0.69 | 0.80 | 0.70 | 0.82 | 1.27 |
P/FCF Ratio | 18.70 | 11.21 | 5.38 | 12.26 | 8.32 | 9.49 |
P/OCF Ratio | 8.45 | 8.08 | 5.07 | 9.82 | 6.78 | 8.95 |
PEG Ratio | - | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 |
EV/Sales Ratio | 0.31 | 0.03 | 0.38 | 0.20 | 0.45 | 1.50 |
EV/EBITDA Ratio | 1.31 | 0.12 | 1.80 | 1.74 | 2.37 | 6.36 |
EV/EBIT Ratio | 1.79 | 0.17 | 2.82 | 4.83 | 3.79 | 9.67 |
EV/FCF Ratio | 2.92 | 0.17 | 1.06 | 1.69 | 2.20 | 5.00 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.02 | 0.04 | 0.10 | 0.25 | 0.10 | 0.07 |
Debt / FCF Ratio | 0.05 | 0.05 | 0.06 | 0.25 | 0.09 | 0.06 |
Net Debt / Equity Ratio | -0.71 | -0.70 | -0.70 | -0.61 | -0.60 | -0.53 |
Net Debt / EBITDA Ratio | -7.07 | -8.04 | -8.10 | -11.28 | -6.65 | -5.16 |
Net Debt / FCF Ratio | -15.78 | -11.57 | -4.76 | -10.98 | -6.17 | -4.06 |
Asset Turnover | 0.41 | 0.40 | 0.40 | 0.46 | 0.44 | 0.43 |
Inventory Turnover | 3.13 | 3.35 | 3.39 | 3.68 | 3.34 | 3.21 |
Quick Ratio | 9.92 | 20.19 | 15.71 | 15.74 | 9.54 | 10.89 |
Current Ratio | 10.50 | 21.34 | 16.57 | 16.99 | 10.24 | 11.71 |
Return on Equity (ROE) | 10.46% | 7.92% | 12.82% | 5.73% | 7.71% | 10.05% |
Return on Assets (ROA) | 4.41% | 3.71% | 3.43% | 1.18% | 3.31% | 4.16% |
Return on Invested Capital (ROIC) | 21.72% | 18.56% | 16.29% | 4.63% | 10.55% | 12.97% |
Return on Capital Employed (ROCE) | 7.30% | 6.00% | 5.50% | 1.90% | 5.60% | 6.80% |
Earnings Yield | 12.00% | 11.29% | 15.49% | 8.21% | 9.53% | 7.79% |
FCF Yield | 5.35% | 8.92% | 18.57% | 8.16% | 12.02% | 10.54% |
Dividend Yield | 3.67% | - | - | 4.33% | 3.99% | 2.78% |
Payout Ratio | 22.97% | 30.42% | 20.36% | 48.86% | 38.43% | 30.65% |
Buyback Yield / Dilution | 0.08% | 0.01% | -0.01% | 0.73% | 2.50% | 0.32% |
Total Shareholder Return | 3.76% | 0.01% | -0.01% | 5.07% | 6.49% | 3.10% |